| Project CADENCE (CAncer Detected Early caN be CurEd) (NCT05633342) | MiRXES Pte Ltd | 2022-07-07 |
| DLCS for Predicting Neoadjuvant Chemotherapy Response (NCT05617469) | Zhejiang Cancer Hospital | 2022-07-01 |
| A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer (NCT05101616) | Shanghai Minimally Invasive Surgery Center | 2022-07-01 |
| Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC) (NCT05431244) | Samsung Medical Center | 2022-07-01 |
| Epidemiology of Helicobacter Pylori Infection in Moscow (NCT05775120) | Moscow Clinical Scientific Center | 2022-07-01 |
| Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy (NCT06202781) | Chinese PLA General Hospital | 2022-07-01 |
| Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric Cancer (NCT05385900) | Xijing Hospital | 2022-06-30 |
| Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells (NCT05410847) | Hebei Medical University | 2022-06-30 |
| Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence (NCT05368636) | Shandong University | 2022-06-30 |
| Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer (NCT05497739) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-06-28 |
| Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients (NCT05274048) | Fox Chase Cancer Center | 2022-06-24 |
| Comprehensive Outcomes for After Cancer Health (NCT05349227) | Pack Health | 2022-06-23 |
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680) | Cue Biopharma | 2022-06-14 |
| GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites (NCT05438459) | Kyushu University | 2022-06-08 |
| Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors (NCT05538195) | Chongqing Precision Biotech Co., Ltd | 2022-06-07 |
| Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer (NCT05618821) | Fujian Medical University | 2022-06-03 |
| Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis (NCT05541146) | Instituto do Cancer do Estado de São Paulo | 2022-06-01 |
| Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) (NCT05361161) | Gang Wu | 2022-06-01 |
| Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT (NCT05430841) | The First Affiliated Hospital of Xiamen University | 2022-06-01 |
| Neoadjuvant TACiE in Locally Advanced Gastric Cancer (NCT05346874) | Shanghai Zhongshan Hospital | 2022-06-01 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer (NCT05395780) | Maxinovel Pty., Ltd. | 2022-06-01 |
| Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and Survival (NCT05287672) | Assiut University | 2022-06-01 |
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients (NCT05411133) | Arbele Pty Ltd | 2022-05-30 |
| A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors (NCT05396300) | Weijia Fang, MD | 2022-05-25 |
| Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin (NCT05379790) | Erasmus Medical Center | 2022-05-25 |
| Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping (NCT06048458) | University College, London | 2022-05-18 |
| A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. (NCT05322577) | Amgen | 2022-05-17 |
| Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer (NCT05177068) | Henan Cancer Hospital | 2022-05-13 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer (NCT05241899) | The First Affiliated Hospital of Zhengzhou University | 2022-05-07 |
| Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer (NCT05397548) | Lin Chen | 2022-05-01 |
| Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma (NCT05540145) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-05-01 |
| Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy. (NCT05390684) | Hospital Universitario La Fe | 2022-05-01 |
| Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer (NCT04782791) | Chinese PLA General Hospital | 2022-05-01 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT05253053) | TransThera Sciences (Nanjing), Inc. | 2022-04-13 |
| (VELA) Study of BLU-222 in Advanced Solid Tumors (NCT05252416) | Blueprint Medicines Corporation | 2022-04-07 |
| GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer (NCT05419362) | Genome & Company | 2022-04-07 |
| The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III (NCT04871412) | Ottawa Hospital Research Institute | 2022-04-04 |
| The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical Gastrectomy (NCT05356156) | The First Affiliated Hospital with Nanjing Medical University | 2022-04-01 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies (NCT05462314) | Viome | 2022-03-29 |
| Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer (NCT05192460) | jianming xu | 2022-03-28 |
| Google Location History Following Oesophagectomy and/or Gastrectomy (NCT05035602) | Imperial College London | 2022-03-24 |
| Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer (NCT06254300) | University of Maia | 2022-03-23 |
| Combined Exercise and Nutritional Intervention in GI Cancer Patients (NCT05420259) | Hospital Beatriz Ângelo | 2022-03-21 |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (NCT05494060) | The First Affiliated Hospital with Nanjing Medical University | 2022-03-16 |
| Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. (NCT05111626) | Amgen | 2022-03-14 |
| The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer. (NCT05354856) | Rigshospitalet, Denmark | 2022-03-11 |
| A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05238883) | HiFiBiO Therapeutics | 2022-03-10 |
| Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (NCT05052801) | Amgen | 2022-03-07 |
| Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer (NCT05227378) | Shen Lin | 2022-03-01 |
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China (NCT05638269) | Zhujiang Hospital | 2022-03-01 |
| Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma (NCT05439993) | Hallym University Medical Center | 2022-03-01 |
| Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE) (NCT05412758) | Imperial College London | 2022-02-28 |
| the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer (NCT05235932) | Fujian Medical University | 2022-02-20 |
| A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer (NCT05165264) | Bristol-Myers Squibb | 2022-02-16 |
| A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer (NCT05216237) | Jiuda Zhao | 2022-02-15 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma (NCT05275062) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-02-15 |
| Specialization in Gastric Cancer Surgery (NCT05280665) | Karadeniz Technical University | 2022-02-14 |
| First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer (NCT05156866) | TORL Biotherapeutics, LLC | 2022-02-02 |
| Upper GI Serial Tumour Biopsies (NCT05233007) | The Christie NHS Foundation Trust | 2022-01-25 |
| The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control Study (NCT05966246) | Gangnam Severance Hospital | 2022-01-25 |
| Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer (NCT03958019) | University of Dublin, Trinity College | 2022-01-25 |
| Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy (NCT05229874) | Hebei Medical University | 2022-01-20 |
| Resilience and Equity in Aging, Cancer, and Health (REACH) (NCT04674267) | Dana-Farber Cancer Institute | 2022-01-18 |
| Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors (NCT04683939) | BioNTech SE | 2022-01-18 |
| A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) (NCT05002127) | ALX Oncology Inc. | 2022-01-15 |
| Validation of a Model for Predicting Anastomotic Leakage (NCT05646290) | Jichao Qin | 2022-01-06 |
| Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy (NCT05465512) | Fujian Medical University | 2022-01-04 |
| ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer (NCT04943484) | Niguarda Hospital | 2022-01-01 |
| Total Versus Partial Omentectomy in the Treatment of Gastric Cancer (NCT05238584) | University of Debrecen | 2022-01-01 |
| A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients (NCT04591028) | Mayo Clinic | 2022-01-01 |
| LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery (NCT04105062) | Washington University School of Medicine | 2021-12-31 |
| Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer (NCT05513144) | chenwu | 2021-12-24 |
| Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） (NCT05113459) | Guoxin Li | 2021-12-18 |
| da Vinci SP Robotic Gastrectomy (NCT05051670) | Yonsei University | 2021-12-16 |
| Efficacy and Safety of ESD for the Treatment of Superficial Gastric Neoplasms (NCT05930860) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-12-12 |
| Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer (NCT04999332) | National Cheng-Kung University Hospital | 2021-12-10 |
| VITAMin Insufficiency in Esophagogastric Neoplasms (NCT05281380) | Zuyderland Medisch Centrum | 2021-12-01 |
| Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers (NCT05205330) | Rottapharm Biotech | 2021-11-23 |
| Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia (NCT05124704) | Wang Jiangling | 2021-11-20 |
| Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) (NCT05076279) | Seoul National University Bundang Hospital | 2021-11-15 |
| Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors (NCT05075993) | M.D. Anderson Cancer Center | 2021-11-12 |
| An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer (NCT04745988) | National Cancer Center Hospital East | 2021-11-11 |
| Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery（STP-LRG-1） (NCT05585437) | Fujian Medical University | 2021-11-11 |
| Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy (NCT05219539) | Fujian Medical University | 2021-11-11 |
| A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013) | Cancer Research UK | 2021-11-10 |
| Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma (NCT05122091) | Guangxi Medical University | 2021-11-05 |
| A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) (NCT05144854) | Ono Pharmaceutical Co., Ltd. | 2021-11-05 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
| Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors (NCT05187338) | Second Affiliated Hospital of Guangzhou Medical University | 2021-11-01 |
| Gastrectomy Outcomes in Elderly Patients (NCT05071755) | Marmara University | 2021-11-01 |
| Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX) (NCT04787354) | Hallym University Medical Center | 2021-11-01 |
| Genomic Evolution of Metastasis in Gastric Cancer (NCT05061082) | University Medical Center Ho Chi Minh City (UMC) | 2021-10-26 |
| Detection of Plasma Circulating Tumor DNA in Gastric Cancer (NCT05027347) | University Medical Center Ho Chi Minh City (UMC) | 2021-10-10 |
| Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma (NCT05184946) | The Second Affiliated Hospital of Shandong First Medical University | 2021-10-09 |
| Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description (NCT05029869) | University Medical Center Ho Chi Minh City (UMC) | 2021-10-04 |
| Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer (NCT05052931) | Jianjun Yang | 2021-10-01 |